Freeman is director of the Women’s Mental Health Center and associate professor of Psychiatry and Obstetrics and Gynecology at the University of Texas–Southwestern Medical Center.
She established the Women’s Mental Health Program at the University of Arizona in 2000, serving as its director for seven years. She recently moved to the University of Texas-Southwestern in Dallas to direct its Women’s Mental Health Center. The program includes research, clinical and teaching components, with an emphasis on mood and anxiety disorders across the female reproductive cycle.
Freeman directs a clinical research program in women’s mental health. She has obtained research support from federal, state, and foundation grants. Her focus is on mood disorders in the context of reproductive events.
In addition, Freeman is the vice editor-in-chief of The Journal of Clinical Psychiatry. She chaired the American Psychiatric Association (APA) Subcommittee on Omega-3 Fatty Acids in Psychiatry (2003-2006). She currently chairs the APA’s Task Force on Complementary and Alternative Medicine and is a member of the APA’s Major Depressive Disorder Practice Guidelines Revision Committee.
Freeman graduated from the University of Wisconsin in 1990 and from Northwestern University Medical School in 1994. Her psychiatry residency was at the Harvard Longwood Psychiatry Residency in Boston. She completed a research fellowship in Biological Psychiatry at the University of Cincinnati.
Stoll AL, Severus WE, Freeman MP, Rueter S, Zboyan HA, Diamond E, Cress KK, Marangell LB. Omega-3 fatty acids in bipolar disorder: a double-blind placebo-controlled trial. Arch Gen Psychiatry, 1999; 56:407-412.
Freeman MP. Omega-3 fatty acids in psychiatry: a review. Ann Clin Psychiatry 2000; 12:159-165.
Freeman MP, Helgason C, Hill R. Selected integrative medicine treatments for depression: considerations for women. Journal of the American Medical Women’s Association 2004; 59:216-224.
Freeman MP, Hibbeln JR, Wisner KL, Brumbach BH, Watchman W, Gelenberg AJ. Randomized dose-ranging pilot trial of omega-3 fatty acids for postnatal depression. Acta Psychiatrica Scandinavica 2006; 113 (1), 31-35.
Freeman MP, Hibbeln JR, Wisner KL, Watchman M, Gelenberg AJ. An open trial of omega-3 fatty acids for depression in pregnancy. Acta Neuropsychiatrica, 2006;18:21-24.
Keck PE, Jr., Mintz J, McElroy SL, Freeman MP, Suppes T, Frye MA, Altshuler LL, Kupka R, Nolen WA, Leverich GS, Denicoff KD, Grunze H, Duan N, Post RM. Double-Blind, Randomized, Placebo-Controlled Trials of Ethyl-Eicosapentanoate in the Treatment of Bipolar Depression and Rapid Cycling Bipolar Disorder. Biological Psychiatry 2006: 60:1020-1022.
Freeman MP, Hibbeln JR, Wisner KL, Davis JM, Mischoulon D, Peet M, Keck PE, Jr., Marangell LB, Richardson AJ, Lake J, Stoll AL. Omega-3 Fatty Acids: Evidence Basis for Treatment and Future Research in Psychiatry [American Psychiatric Association Subcommittee Report]. J Clin Psychiatry 2006; 67:1954-1967.
Freeman MP. Omega-3 fatty acids and perinatal depression: A review of the literature and recommendations for future research. Prostaglandins, Leukotrienes, and Essential Fatty Acids 2006; 75:291-297.
Freeman MP, Sinha P. Tolerabilty of omega-3 fatty acid supplements in perinatal women. Prostaglandins, Leukotrienes, and Essential Fatty Acids 2007;77(3-4):203-208.
Freeman MP, Davis MF, Sinha P, Wisner KL, Hibbeln JR, Gelenberg AJ. Omega-3 Fatty Acids and Supportive Psychotherapy for Perinatal Depression: A Randomized Placebo-Controlled Study. Journal of Affective Disorders, in press.